RxDoctor Payments Data

Christopher Laflure, PA

Medical · Grand Rapids, MINPI 1518070663

Payments from drug & device makers

$1,352in general payments, 2019–2025

Across 46 payments — averaging $29.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$322
  • Johnson & Johnson$212
  • Seagen Inc.$100
  • Endo USA, Inc.$90
  • AbbVie$72
  • Myovant Sciences Inc.$71
  • plus $486 from 17 others

What the payments were for

  • Food & beverage$76957%
  • Education$58343%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,352 in reported general payments places this provider in the 65th percentile of 755 medical providers in Michigan.

See all medical providers in Michigan

Medicare billing

Part B allowed, 2024
$12,761
Medicare patients
97
Services billed
268

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron54$26,265
Tamsulosin Hcl305$5,343
Bicalutamide39$4,737
Finasteride144$2,451
Oxybutynin Chloride ErOxybutynin Chloride41$1,388
Solifenacin Succinate42$1,254
Alfuzosin Hcl ErAlfuzosin Hcl55$787
Pentoxifylline14$341
Cephalexin31$209
Oxybutynin Chloride20$142
Ciprofloxacin Hcl14$73
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$66

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$322$26,26554 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 755 medical providers in Michigan.

Other medical in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →